Visualitza per autor "Postel-Vinay, Sophie"
Ara mostrant els elements 1-1 d 1
-
First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours
Ameratunga, Malaka; Braña Garcia, Irene; Bono, Petri; Postel-Vinay, Sophie; Plummer, Ruth; Aspegren, John (Springer Nature, 2020-12-08)